Home - Products - Others - Other Targets - [2-(4-Chlorophenyl)-1,3-thiazol-4-yl]acetic acid

[2-(4-Chlorophenyl)-1,3-thiazol-4-yl]acetic acid

CAS No. 17969-20-9

[2-(4-Chlorophenyl)-1,3-thiazol-4-yl]acetic acid( 2-[2-(4-CHLOROPHENYL)-1,3-THIAZOL-4-YL]ACETIC ACID )

Catalog No. M22256 CAS No. 17969-20-9

[2-(4-Chlorophenyl)-1,3-thiazol-4-yl]acetic acid is an anti-inflammatory thiazole.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
10MG 41 In Stock
25MG 70 In Stock
50MG 100 In Stock
100MG 150 In Stock
200MG 222 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    [2-(4-Chlorophenyl)-1,3-thiazol-4-yl]acetic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    [2-(4-Chlorophenyl)-1,3-thiazol-4-yl]acetic acid is an anti-inflammatory thiazole.
  • Description
    [2-(4-Chlorophenyl)-1,3-thiazol-4-yl]acetic acid is an anti-inflammatory thiazole.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    2-[2-(4-CHLOROPHENYL)-1,3-THIAZOL-4-YL]ACETIC ACID
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    anti-inflammatory
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    17969-20-9
  • Formula Weight
    253.71
  • Molecular Formula
    C11H8ClNO2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)Cc1c[s]c(n1)c2ccc([Cl])cc2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • HIV-gp41-Fragment

    HIV-gp41-Fragment

  • 2,3,4,5-Tetracaffeoy...

    2,3,4,5-Tetracaffeoyl-D-Glucaric acid is a compound isolated from Inula japonica that inhibits fat accumulation and reduces body fat and can be used in the study of obesity.

  • Isokaempferide

    Isokaempferide shows hepatoprotective, antiproliferative, and anti-inflammatory effects, the anti-inflammatory effects can be explained, at least in part, by reducing neutrophil degranulation, myeloperoxidase activity, mediators as well as TNF-alpha secretion.